Chrome Holding Co. (MEHCQ)

Latest Insider Confidence Score

2025Q4

48.1
Bearish

Company insider confidence (by quarter)

2020Q4 2025Q4

Largest shareholders

Insider Role (last 12 mo) Shares held Filed at
Sc Us (Ttgp), Ltd. — 19,053,588 Jun 25, 2021
SC U.S. Growth VII Management, L.P. — 19,053,588 Jun 25, 2021
Sequoia Capital U.S. Growth Fund VII, L.P. — 19,053,588 Jun 25, 2021
Sequoia Capital U.S. Growth VII Principals Fund, L.P. — 19,053,588 Jun 25, 2021
Scgf III Management Llc — 19,053,588 Jun 25, 2021

Recent buy/sell transactions

Exec date Filing date Insider Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Aug 20, 2025 Aug 21, 2025 Selsavage Joseph Anthony CEO Sell 26.3 -5,232 -5.72% ✗ $19.4K
Jun 9, 2025 Jun 11, 2025 Wojcicki Anne Director Neutral 52.5 - 0.00% ✗ -
May 20, 2025 May 21, 2025 Selsavage Joseph Anthony CEO Sell 26.3 -5,073 -5.26% ✗ $17K
Mar 26, 2025 Kvarda Matthew Chief Restructuring Officer Neutral 52.5 - 0.00% ✗ -
Mar 26, 2025 Walper Thomas B. Director Neutral 52.5 - 0.00% ✗ -
Feb 20, 2025 Feb 21, 2025 Selsavage Joseph Anthony CFO Sell 26.3 -5,654 -5.54% ✗ $15.5K
Nov 20, 2024 Nov 21, 2024 Selsavage Joseph Anthony CFO Sell 26.3 -5,279 -4.92% ✗ $16.6K
Oct 31, 2024 Fernandez Andre J Director Neutral 52.5 - 0.00% ✗ -
Oct 31, 2024 FRANKOLA JIM Director Neutral 52.5 - 0.00% ✗ -
Oct 31, 2024 Jensen Mark Edwin Director Neutral 52.5 - 0.00% ✗ -
Aug 26, 2024 Aug 28, 2024 SCHELLER RICHARD H Director Neutral 90.0 +658,485 277.28% ✗ -
Aug 26, 2024 Aug 28, 2024 MONTGOMERY RICE VALERIE MD Director Neutral 90.0 +853,037 240.37% ✗ -
Aug 26, 2024 Aug 28, 2024 Mohan Neal Director Neutral 90.0 +658,485 267.89% ✗ -
Aug 26, 2024 Aug 28, 2024 Chung Patrick S Director Neutral 90.0 +860,520 285.49% ✗ -
Aug 26, 2024 Aug 28, 2024 BOTHA ROELOF Director Neutral 90.0 +838,071 275.74% ✗ -
Aug 26, 2024 Aug 28, 2024 Taylor Peter J. Director Neutral 90.0 +658,485 204.03% ✗ -
Aug 26, 2024 Aug 28, 2024 Hernandez Sandra R MD Director Neutral 90.0 +808,140 204.56% ✗ -
Aug 20, 2024 Aug 21, 2024 Selsavage Joseph Anthony CFO Sell 26.3 -110,388 -4.89% ✗ $39.2K
Aug 20, 2024 Aug 21, 2024 Richards William G Head of Therapeutics Discovery Sell 26.3 -57,365 -9.10% ✗ $20.4K
Jun 30, 2024 Jul 2, 2024 Taylor Peter J. Director Neutral 90.0 +57,515 21.69% ✗ -
Jun 30, 2024 Jul 2, 2024 MONTGOMERY RICE VALERIE MD Director Neutral 82.5 +15,337 4.52% ✗ -
Jun 30, 2024 Jul 2, 2024 Hernandez Sandra R MD Director Neutral 90.0 +57,515 17.04% ✗ -
May 21, 2024 May 23, 2024 Selsavage Joseph Anthony CFO Neutral 90.0 +1,000,000 79.47% ✗ -
May 20, 2024 May 21, 2024 HIBBS KATHY L Chief Administrative Officer Sell 26.3 -35,282 -2.82% ✗ $19.3K
May 20, 2024 May 21, 2024 Selsavage Joseph Anthony CFO Sell 26.3 -36,913 -2.85% ✗ $20.2K
May 20, 2024 May 21, 2024 Richards William G Head of Therapeutics Discovery Sell 27.5 -16,106 -2.49% ✗ $8.8K
May 2, 2024 May 6, 2024 HIBBS KATHY L Chief Administrative Officer Sell 45.0 -38,551 -2.99% ✓ $19K
Apr 18, 2024 Apr 19, 2024 HIBBS KATHY L Chief Administrative Officer Sell 45.0 -38,548 -2.99% ✓ $18.1K
Apr 4, 2024 Apr 5, 2024 HIBBS KATHY L Chief Administrative Officer Sell 45.0 -38,548 -2.99% ✓ $19.3K
Mar 21, 2024 Mar 22, 2024 HIBBS KATHY L Chief Administrative Officer Sell 45.0 -38,548 -2.99% ✓ $17.9K
Mar 7, 2024 Mar 11, 2024 HIBBS KATHY L Chief Administrative Officer Sell 45.0 -38,548 -2.99% ✓ $20.4K
Feb 22, 2024 Feb 23, 2024 HIBBS KATHY L Chief Administrative Officer Sell 41.3 -38,548 -3.02% ✓ $23.3K
Feb 20, 2024 Feb 21, 2024 Richards William G Head of Therapeutics Discovery Sell 26.3 -18,497 -2.78% ✗ $13.2K
Feb 20, 2024 Feb 21, 2024 Selsavage Joseph Anthony CFO Sell 26.3 -42,395 -3.22% ✗ $30.4K
Feb 20, 2024 Feb 21, 2024 HIBBS KATHY L Chief Administrative Officer Sell 26.3 -40,522 -3.16% ✗ $29K
Feb 15, 2024 Feb 16, 2024 HIBBS KATHY L Chief Administrative Officer Sell 45.0 -38,548 -2.92% ✓ $30.2K
Jan 25, 2024 Jan 26, 2024 HIBBS KATHY L Chief Administrative Officer Sell 45.0 -38,548 -2.92% ✓ $28K
Jan 11, 2024 Jan 12, 2024 HIBBS KATHY L Chief Administrative Officer Sell 45.0 -38,548 -2.92% ✓ $27.6K
Dec 28, 2023 Dec 29, 2023 HIBBS KATHY L Chief Administrative Officer Sell 45.0 -38,548 -2.92% ✓ $35.9K
Dec 14, 2023 Dec 18, 2023 HIBBS KATHY L Chief Administrative Officer Sell 45.0 -38,548 -2.92% ✓ $37.2K
Nov 30, 2023 Dec 1, 2023 HIBBS KATHY L Chief Administrative Officer Sell 45.0 -38,548 -2.92% ✓ $33.8K
Nov 20, 2023 Nov 21, 2023 HIBBS KATHY L Chief Administrative Officer Sell 45.0 -4,627 -0.36% ✗ $4.2K
Nov 20, 2023 Nov 21, 2023 Richards William G Head of Therapeutics Discovery Sell 37.5 -5,695 -0.85% ✗ $5.2K
Nov 20, 2023 Nov 21, 2023 Selsavage Joseph Anthony CFO Sell 45.0 -6,208 -0.47% ✗ $5.6K
Nov 16, 2023 Nov 17, 2023 HIBBS KATHY L Chief Administrative Officer Sell 45.0 -38,548 -2.91% ✓ $29.7K
Nov 2, 2023 Nov 3, 2023 HIBBS KATHY L Chief Administrative Officer Sell 45.0 -38,548 -2.91% ✓ $33.4K
Oct 19, 2023 Oct 20, 2023 HIBBS KATHY L Chief Administrative Officer Sell 45.0 -38,548 -2.91% ✓ $31.4K
Oct 5, 2023 Oct 6, 2023 HIBBS KATHY L Chief Administrative Officer Sell 45.0 -38,548 -2.91% ✓ $32.4K
Sep 21, 2023 Sep 25, 2023 HIBBS KATHY L Chief Administrative Officer Sell 45.0 -38,548 -2.91% ✓ $38.6K
Sep 15, 2023 Sep 19, 2023 Wojcicki Anne CEO Neutral 52.5 - 0.00% ✗ -
Sep 15, 2023 Sep 19, 2023 Selsavage Joseph Anthony CFO Neutral 90.0 +1,025,992 346.30% ✗ -
Sep 15, 2023 Sep 19, 2023 Richards William G Head of Therapeutics Discovery Neutral 90.0 +459,691 217.82% ✗ -
Sep 15, 2023 Sep 19, 2023 HIBBS KATHY L Chief Administrative Officer Neutral 90.0 +1,025,992 396.16% ✗ -
Sep 7, 2023 Sep 11, 2023 HIBBS KATHY L Chief Administrative Officer Sell 28.8 -40,894 -13.64% ✓ $43.5K
Sep 6, 2023 Sep 8, 2023 Hernandez Sandra R MD Director Neutral 90.0 +194,363 135.74% ✗ -
Sep 6, 2023 Sep 8, 2023 SCHELLER RICHARD H Director Neutral 90.0 +165,088 228.06% ✗ -
Sep 6, 2023 Sep 8, 2023 MONTGOMERY RICE VALERIE MD Director Neutral 90.0 +190,495 127.81% ✗ -
Sep 6, 2023 Sep 8, 2023 Mohan Neal Director Neutral 90.0 +154,997 170.68% ✗ -
Sep 6, 2023 Sep 8, 2023 Chung Patrick S Director Neutral 90.0 +188,387 166.66% ✗ -
Sep 6, 2023 Sep 8, 2023 BOTHA ROELOF Director Neutral 90.0 +193,379 174.91% ✗ -
Sep 6, 2023 Sep 8, 2023 Taylor Peter J. Director Neutral 90.0 +137,566 107.77% ✗ -
Sep 5, 2023 Sep 6, 2023 Richards William G Head of Therapeutics Discovery Sell 27.5 -2,538 -1.19% ✗ $2.7K
Aug 24, 2023 Aug 25, 2023 HIBBS KATHY L Chief Administrative Officer Sell 28.8 -40,894 -13.94% ✓ $43.1K
Aug 20, 2023 Aug 22, 2023 HIBBS KATHY L Chief Administrative Officer Sell 27.5 -4,628 -1.80% ✗ $5.3K
Aug 20, 2023 Aug 22, 2023 Selsavage Joseph Anthony CFO Sell 27.5 -6,209 -2.12% ✗ $7.1K
Aug 20, 2023 Aug 22, 2023 Richards William G Head of Therapeutics Discovery Sell 27.5 -8,185 -3.73% ✗ $9.3K
Aug 15, 2023 Aug 16, 2023 HIBBS KATHY L Chief Administrative Officer Sell 25.0 -40,894 -13.72% ✓ $53.9K
Aug 11, 2023 Richards William G Head of Therapeutics Discovery Neutral 52.5 - 0.00% ✗ -
Jul 27, 2023 Jul 31, 2023 HIBBS KATHY L Chief Administrative Officer Sell 25.0 -40,894 -13.72% ✓ $77.3K
Jul 13, 2023 Jul 14, 2023 HIBBS KATHY L Chief Administrative Officer Sell 25.0 -40,894 -13.72% ✓ $74.2K
Jun 29, 2023 Jun 30, 2023 HIBBS KATHY L Chief Administrative Officer Sell 25.0 -40,894 -13.72% ✓ $70.4K
Jun 5, 2023 Jun 7, 2023 HIBBS KATHY L Chief Administrative Officer Sell 91.3 +28,561 12.50% ✗ $31.4K
Jun 5, 2023 Jun 7, 2023 Hillan Kenneth J. Chief Therapeutics Officer Sell 91.3 +29,034 15.06% ✗ $31.9K
Jun 5, 2023 Jun 7, 2023 Selsavage Joseph Anthony CFO Sell 86.3 +24,733 9.23% ✗ $27.2K
May 20, 2023 May 23, 2023 Selsavage Joseph Anthony CFO Sell 26.3 -6,209 -2.26% ✗ $12K
May 20, 2023 May 23, 2023 Hillan Kenneth J. Chief Therapeutics Officer Sell 27.5 -4,628 -2.34% ✗ $9K
May 20, 2023 May 23, 2023 HIBBS KATHY L Chief Administrative Officer Sell 27.5 -4,628 -1.98% ✗ $9K
Feb 20, 2023 Feb 22, 2023 Hillan Kenneth J. Chief Therapeutics Officer Sell 26.3 -5,457 -2.77% ✗ $15.7K
Feb 20, 2023 Feb 22, 2023 Selsavage Joseph Anthony CFO Sell 26.3 -7,321 -2.64% ✗ $21K
Feb 20, 2023 Feb 22, 2023 HIBBS KATHY L Chief Administrative Officer Sell 26.3 -5,457 -2.31% ✗ $15.7K
Dec 5, 2022 Dec 6, 2022 HIBBS KATHY L Chief Administrative Officer Sell 25.0 -26,259 -10.02% ✓ $85.3K
Nov 20, 2022 Nov 22, 2022 Selsavage Joseph Anthony CFO Sell 26.3 -10,105 -3.52% ✗ $30.2K
Nov 20, 2022 Nov 22, 2022 HIBBS KATHY L Chief Administrative Officer Sell 26.3 -4,628 -1.74% ✗ $13.8K
Nov 20, 2022 Nov 22, 2022 Hillan Kenneth J. Chief Therapeutics Officer Sell 26.3 -4,628 -2.29% ✗ $13.8K
Nov 11, 2022 Nov 14, 2022 SCHELLER RICHARD H Director Sell 22.5 -18,421 -20.29% ✗ $59.7K
Sep 6, 2022 Sep 8, 2022 Mohan Neal Director Neutral 90.0 +14,633 19.21% ✗ -
Sep 6, 2022 Sep 8, 2022 SCHELLER RICHARD H Director Neutral 90.0 +14,633 19.21% ✗ -
Sep 6, 2022 Sep 8, 2022 BOTHA ROELOF Director Neutral 90.0 +17,884 19.30% ✗ -
Sep 6, 2022 Sep 8, 2022 Chung Patrick S Director Neutral 90.0 +18,047 19.00% ✗ -
Sep 6, 2022 Sep 8, 2022 Taylor Peter J. Director Neutral 90.0 +14,633 12.95% ✗ -
Sep 6, 2022 Sep 8, 2022 Hernandez Sandra R MD Director Neutral 90.0 +17,884 14.27% ✗ -
Sep 6, 2022 Sep 8, 2022 MONTGOMERY RICE VALERIE MD Director Neutral 90.0 +18,210 13.92% ✗ -
Sep 1, 2022 Sep 2, 2022 Selsavage Joseph Anthony CFO Neutral 90.0 +129,761 82.32% ✗ -
Sep 2, 2022 Selsavage Joseph Anthony CFO Neutral 52.5 - 0.00% ✗ -
Aug 25, 2022 Aug 29, 2022 Hernandez Sandra R MD Director Neutral 90.0 +70,956 130.56% ✗ -
Aug 25, 2022 Aug 29, 2022 MONTGOMERY RICE VALERIE MD Director Neutral 90.0 +75,576 136.76% ✗ -
Aug 25, 2022 Aug 29, 2022 Chung Patrick S Director Neutral 90.0 +76,566 415.65% ✗ -
Aug 25, 2022 Aug 29, 2022 BOTHA ROELOF Director Neutral 90.0 +74,256 403.11% ✗ -
Aug 25, 2022 Aug 29, 2022 SCHELLER RICHARD H Director Neutral 90.0 +57,755 313.53% ✗ -
Aug 25, 2022 Aug 29, 2022 Mohan Neal Director Neutral 90.0 +57,755 313.53% ✗ -